RFZ-21349-82345
3 vaccinations
2 coded responses
39 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 303 / GA
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-04-16
- 2021-04-17
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-19
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-28
- 2021-07-14
- 2021-10-13
-
2021-12-18
Dose 3 — Moderna
-
2021-12-18
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-20
-
2021-12-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Chills, Fatigue or tirednessAdult check-in
- 2021-12-22
- 2021-12-23
- 2021-12-24
- 2021-12-27
- 2022-01-02
- 2022-01-08
- 2022-01-16
- 2022-01-23
- 2022-01-31
- 2022-03-21
-
2022-06-19
Survey response — 6 months, dose 3MedDRA: Allergic respiratory symptom, Fatigue, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activitiesFree text: Mild cold/allergy symptoms - head and chest congestion, fatigue, sore throat.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-18
Survey response — 12 months, dose 3MedDRA: COVID-19, Diarrhoea, Dyspnoea, Fatigue, Oropharyngeal pain, Pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Caught COVID19 - exhaustion, fever, body aches, sore throat, diarrhea, mild difficulty breathingMedDRA releases: 2024-11 · check-in free text available
-
2022-12-18
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-12-18 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — 6 months, dose 3
Symptoms: Mild cold/allergy symptoms - head and chest congestion, fatigue, sore throat.
Release 12 — 12 months, dose 3
Symptoms: Caught COVID19 - exhaustion, fever, body aches, sore throat, diarrhea, mild difficulty breathing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Allergic respiratory symptom | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release